What is the Return on Assets (ROA) of Gamida Cell this year?
The Return on Assets (ROA) of Gamida Cell is 0 undefined this year.
Gamida Cell ROA 2024
Gamida Cell ROA
0
Ticker
GMDAQ
ISIN
IL0011552663
WKN
A2N7XM
In 2024, Gamida Cell's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.
Gamida Cell Aktienanalyse
What does Gamida Cell do?
The company Gamida Cell Ltd was founded in 1998 in Jerusalem, Israel and is involved in the development and manufacture of cell therapy products for various diseases. The company has had an exciting history since its inception, including a number of successes and milestones. Gamida Cell's business model is based on the production of cell therapy products for patients suffering from severe diseases. These include blood diseases such as leukemia, lymphoma, or sickle cell anemia. The company uses a unique technology platform called "NiCord," which allows for the extraction and expansion of cells from umbilical cord blood to provide a larger number of cells for transplantation. This platform offers a way to overcome some of the limitations and challenges associated with the use of bone marrow or stem cell donors. Gamida Cell has made significant progress in the development of cell therapy products in recent years. The company is currently working on the development of therapies for various indications such as blood diseases, solid tumors, and autoimmune diseases. Another goal of Gamida Cell is to use its technology platform for the development of drugs for other indications. The company has various divisions in which it operates. The primary division is research and development of cell therapies. However, the company also has a manufacturing facility for the production of its products and a clinical studies department responsible for conducting studies and tests of therapeutics. Gamida Cell collaborates closely with research institutions and other companies in the biotechnology industry to further develop its technology platform and advance the progress of cell therapies overall. Gamida Cell currently offers a range of products, starting with its flagship product "NiCord." NiCord is a cell therapy made from umbilical cord blood cells and can be used for transplantation in patients with blood diseases such as leukemia or lymphoma. The company is also working on the development of additional products, including a cell therapy for solid tumors and a treatment for autoimmune diseases. In recent years, Gamida Cell has received several awards and recognitions. The company has attracted several leading scientists and researchers who collaborate closely with Gamida Cell to further develop the company's technology platform and create new therapies. At the same time, Gamida Cell has also carried out several capital increases to advance research and product development. Overall, Gamida Cell has an excellent reputation in the biotech industry. The company has shown that it can play a leading role in the development of cell therapies that can improve the lives of patients with severe diseases. With the growing demand for new treatment options and the rapid progress in the field of biotech, Gamida Cell is well positioned to continue expanding and developing new therapies that have the potential to change the lives of millions of people worldwide. Gamida Cell ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Gamida Cell's Return on Assets (ROA)
Gamida Cell's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Gamida Cell's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Gamida Cell's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Gamida Cell’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Gamida Cell stock
What was the ROA of Gamida Cell compared to the previous year?
The ROA of Gamida Cell has increased by 0% compared to the previous year.
What consequences do high ROA have for investors of Gamida Cell?
A high ROA is advantageous for investors of Gamida Cell, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Gamida Cell?
A low ROA can be unfavorable for investors of Gamida Cell as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Gamida Cell affect the company?
An increase in ROA of Gamida Cell can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Gamida Cell impact the company?
A reduction in the ROA of Gamida Cell can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Gamida Cell?
Some factors that can influence the ROA of Gamida Cell include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Gamida Cell important for investors?
The ROA of Gamida Cell is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Gamida Cell take to improve ROA?
To improve ROA, Gamida Cell can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Gamida Cell pay?
Over the past 12 months, Gamida Cell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gamida Cell is expected to pay a dividend of 0 USD.
What is the dividend yield of Gamida Cell?
The current dividend yield of Gamida Cell is .
When does Gamida Cell pay dividends?
Gamida Cell pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Gamida Cell?
Gamida Cell paid dividends every year for the past 0 years.
What is the dividend of Gamida Cell?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Gamida Cell located?
Gamida Cell is assigned to the 'Health' sector.
Wann musste ich die Aktien von Gamida Cell kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Gamida Cell from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.
When did Gamida Cell pay the last dividend?
The last dividend was paid out on 12/12/2024.
What was the dividend of Gamida Cell in the year 2023?
In the year 2023, Gamida Cell distributed 0 USD as dividends.
In which currency does Gamida Cell pay out the dividend?
The dividends of Gamida Cell are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Gamida Cell
Our stock analysis for Gamida Cell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gamida Cell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.